Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is 6.77% vs 7.84% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 327.56% vs -181.41% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is 121.90% vs -60.40% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
Compare Quarterly Results Of Chongqing Pharscin Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 6.77% vs 7.84% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -11.21% vs 4.46% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 327.56% vs -181.41% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -28.47% vs 0.00% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 121.90% vs -60.40% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -52.80% vs 4.89% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025






